1. Jiang, Zhi-Gang, Fuller, Steven A., Ghanbari, Hossein A.  “PAN-811 Blocks Chemotherapy Drug-Induced in Vitro Neurotoxicity, while Not Affecting Suppression of Cancer Cell Growth.”  Oxidative Medicine and Cellular Longevity.  Special issue: "Oxidative Stress and Cancer: Advances and Challenges.” Hindawi Publishing Corp.  2016:9392404, (2016). 
  2. Jiang, ZG, Ghanbari, HA: “Different gene products with a similar role in neuronal defense against oxidative stress―heme oxygenase system.”  Chapter 3 in:  Genomics and Proteomics.  eds. Thangadurai, D., Sangeetha, J., Bioscience Publications, pp. 35-42, (2014).
  3. Li, J., O, W., Li, W., Jiang, Z. G., Ghanbari, H.A.:  “Oxidative Stress and Neurodegenerative Disorders.”  International Journal of Molecular Sciences.  14:24438-24475, (2013).
  4. Jiang, ZG, Ghanbari, HA:  “Pathogenesis and therapeutical strategy of Alzheimer’s disease.”  Chapter 11 in:  The Role of Oxidative Stress, Mitochondria Failure and Vascular Hypoperfusion in the Pathogenesis of Alzheimer's Disease.  Research Signpost, Inc., Eds. Aliev, G.  Perry. G., pp. 237-254, (2011).
  5. Pan, W, Dancik, CM, Nelson, VM, Jiang, ZG, Lebowitz, MS, Ghanbari, HA:  “A novel neuroprotectant PAN-811 protects neurons from oxidative stress.”  Central European Journal of Biology.  4(1):34-40, (2009).
  6. Nelson, VM, Dancik, CM, Pan, W, Jian, ZG, Lebowitz, MS, Ghanbari, HA:  “PAN-811 Inhibits Oxidative Stress-Induced Cell Death of Human Alzheimer’s Disease-Derived and Age-Matched Olfactory Neuroepithelial Cells Via Suppression of Intracellular Reactive Oxygen Species.”  Journal of Alzheimer’s Disease.  16:1-9, (2009).
  7. Jiang, ZG, Ghanbari, HA: “Different gene products with a similar role in neuronal defense against oxidative stress―heme oxygenase system.”  Chapter 6 in:  Genomics and Proteomics.  Bioscience Publications, pp. 95-105, (2007).
  8. Chen, RW, May Lu, XC, Yao, C, Liao, Z, Jiang, ZG, Wei, H, Ghanbari, HA, Tortella, FC, Dave, JR:  “PAN-811 Provides Neuroprotection Against Gluamate Toxicity by Suppressing Activation of JNK and p38 MAPK.” Neuroscience Letters. 422:64-67, (2007).
  9. Jiang, ZG, Ghanbari, H:  “PAN-811: A Potential Drug for Alzheimer’s Diseases.”  10th International Conference on Alzheimer’s Disease and Related Disorders, Medimond S.r.l.  pp. 317-322, (2006).
  10. Jiang, ZG, Lebowitz, MS, Ghanbari, HA: “Neuroprotective Activity of 3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone (PAN-811), a Cancer Therapeutic Agent.” CNS Drug Review.  12(1):77-90, (2006).
  11. Jiang, Z-G; May Lu, X-C; Nelson, V; Yang, X-F; Pan, W; Chen, R-W; Lebowitz, MS; Almassian, B; Tortella, FC; Brady, RO; Ghanbari, HA.: “A Multi-functional Cytoprotective Agent that Reduces NeurodegenerationAfter Ischemia.”   Proceedings of the National Academy of Sciences of the USA (PNAS). 103(5):1581-1586, (2006).
  12. Chen RW, Yao C, Lu XC, Jiang ZG, Whipple R, Liao Z, Ghanbari HA, Almassian B, Tortella RC, Davis Jr.: “PAN-811 (3-aminopyridine-2-carboxaldehyde thiosemicarbazone), A Novel Neuroprotectant, Elicits its Function in Primary Neuronal Cultures by Up-Regulating BCL-2 Expression.” Neuroscience, 135:191-201, (2005).
  13. Liu, Q., Smith, M.A., Avila, J., DeBernardia, J., Kansal, M., Takeda, A., Zhu, X., Nunomura, A., Ghanbari, H.A., et al: “Alzheimer-specific epitopes of tau represent lipid peroxidation-induced conformations.” Free Radical Biology and Medicine, 38; 746-754 (2005).
  14. Ghanbari, H.A., Ghanbari, K., Harris, P.L., Jones, P.K., Kubat, Z., Castellani, R.J., Wolozin, B.L., Smith, M.A., Perry, G. “Oxidative damage in cultured human olfactory neurons from Alzheimer’s disease patients.” Aging Cell, 3:41-44, (2004). 
  15. Lee, H.G., Ogawa, O., Zhu, X., O’Neill, M.J., Petersen, R.B., Ghanbari, H., Castellani, R.J., Perry, G. and Smith, M.A.  “Aberrant expression of metabotropic glutamate receptor 2 in the vulnerable neurons of Alzheimer disease.”  Acta Neuropathologica, 107:365-371, (2004).    
  16. Perry, G; Castellani, R.J.; Smith, M.A.; Harris, P.L.R.; Kubat, Z.; Ghanbari, K.; Jones, P.K.; Cordone, G.; Tabaton, M.; Wolozin, B.; Ghanbari, H.: “Oxidative damage in the olfactory system in Alzheimer’s disease.” Acta Neuropathologica, 106:552-556, (2003).
  17. Ogawa,O., Zhu, X., Lee, H.G., Raina, A., Obrenovich, M.E., Bowser, R., Ghanbari, H.A., Castellani, R. J., Perry, G., Smith, M.A.: “Ectopic Localization of Phosphorylated Histone H3 in Alzheimer’s disease: A mitotic Catastrophe?”, Acta Neuropathologica, 105:524-528, (2003).
  18. Lee, H.G., Zhu, X, Ghanbari, H.A., Ogawa, O., Raina, A.K., O’Neill, M.J., Perry, G., Smith, M.A.: “Differential Regulation of Glutamate Receptors in Alzheimer’s Disease.” Neurosignals, 11:282-292, (2002). 
  19. Nunomura A, Perry G., Aliev G., Hirai K., Takeda A, Balraj E.K., Jones P.K., Ghanbari H.A., Wataya T., Shimohama S., Chiba S., Atwood C.S., Petersen R.B., Smith M.A.: “Oxidative Damage is the Earliest Event in Alzheimer Disease.” Journal of Neuropathology and Experimental Neurology, 60:759-67, (2001). 
  20. Harris P.L., Zhu X., Pamies C., Rottkamp C.A., Ghanbari H.A., McShea A., Feng Y., Ferris D.K., Smith M.A.: “Neuronal polo-like kinase in Alzheimer disease indicates cell cycle changes.” Neurobiology of Aging, 21:837-41, (2000).
  21. Zhu X, Rottkamp C.A., Raina A.K., Brewer G.J., Ghanbari H.A., Boux H., Smith M.A.:“Neuronal CDK7 in hippocampus is related to aging and Alzheimer disease.” Neurobiology of Aging, 21:807-813, (2000).
  22. Ghanbari, H.A.: “Risk Factors Versus Alzheimer’s Disease or Symptoms Associated with Alzheimer’s Disease.” Journal of Alzheimer's Disease 2:117, (2000).